metricas
covid
Buscar en
Gastroenterología y Hepatología
Toda la web
Inicio Gastroenterología y Hepatología Aumento de la litogenicidad biliar tras la administración conjunta de nutrició...
Información de la revista
Vol. 24. Núm. 7.
Páginas 321-326 (enero 2001)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 24. Núm. 7.
Páginas 321-326 (enero 2001)
Acceso a texto completo
Aumento de la litogenicidad biliar tras la administración conjunta de nutrición parenteral total y octreótida. Un modelo de formación de cálculos de palmitato cálcico
Increased bile lithogenicity after simultaneous total parenteral nutrition and octreotide. a model of calcium palmitate gallstones
Visitas
10662
J.M. Rodríguez Santiagoa, E.M. Targaronab,
Autor para correspondencia
13882ets@comb.es

Correspondencia: Dr. E.M. Targarona. Servicio de Cirugía General. Hospital de la Santa Creu i Sant Pau. Avda. Pare Claret, 167. 08025 Barcelona
, E. Rosc, J. Martínezc, E. Pocac, M. Velac, J. Massód, A. Nadale, C. Marcoa, M. Triasb
a Servicio de Cirugía General. Hospital Mutua de Terrassa. Universidad de Barcelona
b Servicio de Cirugía General. Hospital de la Santa Creu i Sant Pau
c Institut de Malalties Digestives. Institut d'Investigacions Biomèdiques August Pi-Sunyer (IDIBAPS). Hospital Clínic. Universidad de Barcelona
d Servicio de Farmacología Clínica. Hospital Clínic. Universidad de Barcelona
e Laboratorio de Patología. Hospital Casa de Maternitat. Hospital Clínic. Universidad de Barcelona
Este artículo ha recibido
Información del artículo
Resumen
Bibliografía
Descargar PDF
Estadísticas
Resumen

La estasis vesicular y la formación de cálculos son alteraciones conocidas tras la administración prolongada de la nutrición parenteral y del tratamiento con octreótida. La administración conjunta de ambos tratamientos, por ejemplo en las fístulas intestinales, puede potenciar estos efectos nocivos de ambos fármacos en la función hepatobiliar. En este estudio se ha valorado el riesgo en la formación de litiasis vesicular y alteraciones hepáticas durante el tratamiento con nutrición parenteral total y octreótida por separado y de forma conjunta. Para ello se estudiaron 32 conejos New Zealand distribuidos en 4 grupos durante un período de 2 semanas: 14 controles, seis alimentados con nutrición parenteral total, seis con dieta oral y administración de octreótida y otros seis a los que se administró nutrición parenteral total y octreótida. Al finalizar las 2 semanas se canuló el conducto hepático, se realizó la colecistectomía y una cuña de tejido hepático para su estudio histológico. Se determinó el volumen vesicular y en la bilis hepática y vesicular se valoraron los lípidos biliares, la bilirrubina, el calcio y las proteínas totales, y se llevó a cabo el examen microscópico de la bilis. Se analizó la composición química de los cálculos. Los resultados sugieren que, en nuestro modelo experimental, la administración de nutrición parenteral y octreótida de forma conjunta presenta un efecto aditivo en la estasis vesicular y en la litogénesis biliar. La administración de estas 2 terapias puede ser un modelo de la formación de cálculos de palmitato cálcico en estos animales.

Gallbladder stasis and gallstone formation are well-known complications of both fasting-associated total parenteral nutrition (TPN) and long-term treatment with octreotide. Additive noxious effects to hepatobiliary function may develop when both therapies are given together as treatment of enteric fistulae. The aim of this study was to assess the risk of gallstone formation during treatment with TPN and octreotide separately and in combination. We studied four groups of New Zealand rabbits (n = 32) during a 2-week intervention period: 14 chow-fed controls; 6 fasted and TPN-fed; 6 chow-fed and administered octreotide, and 6 fasted and treated with both TPN and octreotide. After treatment, the bile duct was cannulated and the gallbladder and liver tissue were obtained for histological analysis. Hepatic and gallbladder bile were retrieved for microscopic examination and measurement of biliary lipids, bilirubin, calcium, total protein, and cholesterol nucleation time. The chemical composition of gallstones was also analyzed. The results of the study suggest that simultaneous administration of these two therapies in rabbits has additive effects on gallbladder stasis and bile lithogenicity. The administration of both treatments can play an important role in the formation of calcium palmitate gallstones in these animals.

El Texto completo está disponible en PDF
Bibliografía
[1.]
B.I. Fein, P.R. Holt.
Hepatobiliary complications of total parenteral nutrition.
J Clin Gastroenterol, 18 (1994), pp. 62-66
[2.]
E.M.M. Quigley, M.N. Marsh, J.L. Shaffer, R.S. Markin.
Hepatobiliary complications of total parenteral nutrition.
Gastroenterology, 104 (1993), pp. 286-301
[3.]
E.E. Gleghorn, R.J. Merritt, D.L. Henton, H.M. Neusterin, B. Landing, F.R. Sinatra.
A subacute rabbit model for hepatobiliary dysfunction during total parenteral nutrition.
J Ped Gastroenterol Nutr, 9 (1989), pp. 247-255
[4.]
J.B. Das, N.D. Poulos, G.G. Ansari.
Biliary lipid composition and bile acid profiles during and after enteral fast of total parenteral nutrition in the rabbit.
J Pediatr Gastroenterol Nutr, 22 (1996), pp. 85-91
[5.]
B. Messing, C. Bories, F. Kunstlinger, J.J. Bernier.
Does total parenteral nutrition induce gallbladder sludge formation and lithiasis?.
Gastroenterology, 84 (1983), pp. 1012-1019
[6.]
J.J. Roslyn, H.A. Pitt, L.L. Mann, M.E. Ament, L. Den Besten.
Gallbladder disease in patients on long term parenteral nutrition.
Gastroenterology, 84 (1983), pp. 148-154
[7.]
P. Nubiola, J.M. Badía, F. Martínez-Rodenas, M.J. Gil, M. Segura, J. Sancho, et al.
Treatment of 27 post-operative enterocutaneous fistulas with the long half-life somatostatin analogue SMS 201-995.
Ann Surg, 210 (1989), pp. 56-58
[8.]
P. Nubiola-Calonge, J.M. Badía, J. Sancho, M.J. Gil, M. Segura, A. Sitges-Serra.
Blind evaluation of the effects of octreotide (SMS 201-995), a somatostatin analogue, on small bowel fistula output.
Lancet, 11 (1987), pp. 674-676
[9.]
J.J. Sancho, J. Di Constanzo, P. Nubiola, A. Larrad, A. Beguiristain, F. Roqueta, et al.
Randomized double-blind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistula.
Br J Surg, 82 (1995), pp. 638-641
[10.]
P. Martineau, J.A. Shwed, R. Denis.
Is octreotide a new hope for enterocutaneous and external pancreatic fistulas closure?.
Am J Surg, 172 (1996), pp. 386-395
[11.]
H. Friess, I. Kempla, P. Hermanek.
The role of somatostatin and octreotide in pancreatic disease.
Digestion, 55 (1993), pp. 37-44
[12.]
S.T. Williams, J.C. Cooper, A.T. Axon, R.F. King, M. Barker.
Use of a long acting somatostatin analogue in controlling life threatening ileostomy diarrhoea.
BMJ, 289 (1984), pp. 1027-1028
[13.]
R.J. Long, T.E. Adrian, S.R. Bloom.
Somatostatin and the dumping syndrome.
BMJ, 290 (1985), pp. 445-449
[14.]
P.G. Reasbecck, A.M. Van Rij.
The effect of somatostatin on the dumping after gastric surgery. A preliminary report.
Surgery, 99 (1986), pp. 442-468
[15.]
J.P. Cello, J. Grendell, P. Basuk.
Controlled clinical trial of octreotide for refractory AIDS-associated diarrhoea.
Gastroenterology, 98 (1990), pp. A163
[16.]
L.E. Buscail, J.P. Tauber, J. Escourrou.
Gallstone formation and occurrence of cholesterol monohydrate crystals in gallbladder bile of patients with long-term sandostatin treatment.
Gastroenterology, 96 (1989), pp. A580
[17.]
R.H. Dowling, S.H. Hussaini, G.M. Murphy, J.A.H. Wass.
Gallstones during octreotide therapy.
Digestion, 54 (1993), pp. 107-120
[18.]
G.W. Bigg-Wither, K.K. Ho, R. Grunstein, C.E. Sullivan, B.D. Doust.
Effects of long term octreotide on gallstone formation and gallbladder function.
BMJ, 304 (1992), pp. 1611-1612
[19.]
S.A. Ahrendt, G.E. McGuire, H.A. Pitt, K.D. Lillemoe.
Why somatostatin cause gallstones?.
Am J Surg, 161 (1991), pp. 177-182
[20.]
A.J. Moser, D. Giurgiu, K. Morgenstern, Z.R. Abedin, J.J. Roslyn, M.Z. Abedin.
Octreotide stimulates Ca++ secretion by the gallbladder: a risk factor for gallstones.
Surgery, 125 (1999), pp. 509-513
[21.]
A.J. Moser, M.Z. Abedin, D.I.N. Giurgiu, J.J. Roslyn.
Octreotide promotes gallbladder absorption in prairie dogs: A potential cause of gallstones.
Gastroenterology,, 108 (1995), pp. 1547-1555
[22.]
G.R. Bartlett.
Phosphorus assay in column chromatography.
J Biol Chem, 234 (1959), pp. 466-468
[23.]
H. Fromm, P. Amin, H. Klein, I. Kupke.
Use of a simple enzymatic assay of cholesterol analysis in human bile.
J Lipid Res, 21 (1980), pp. 259-261
[24.]
P. Talalay.
Enzymatic analysis of steroid hormones.
Methods Biol Chem, 8 (1960), pp. 115-143
[25.]
E.M. Brett, J.M. Hicks, D.M. Powers, R.N. Rand.
Delta bilirubin in serum of pediatric patients: correlation with age and disease.
Clin Chem, 30 (1984), pp. 1561-1563
[26.]
O.H. Lowry, N.J. Rosebrough, A.L. Farr.
Protein measurement with the Folin phenol reagent.
J Biol Chem, 193 (1951), pp. 265-275
[27.]
E. Ros, S. Navarro, I. Fernández, M. Reixach, J.M. Ribó, J. Rodés.
Utility of biliary microscopy for the prediction of the chemical composition of gallstones and the outcome of dissolution therapy with ursodeoxycholic acid.
Gastroenterology, 91 (1986), pp. 703-712
[28.]
E. Muller, P.A. Grace, H.A. Pitt.
The effect of parenteral nutrition on biliary calcium and bilirrubin.
J Surg Res, 40 (1986), pp. 55-62
[29.]
S.H. Hussaini, S.P. Pereira, M.J. Veysey, C. Kennedy, P. Jenkins, G.M. Murphy, et al.
Roles of gallbladder emptying and intestinal transit in the pathogenesis of octreotide induced gallbladder stones.
Gut, 38 (1996), pp. 775-783
[30.]
P.A. Van Liessum, W.P.M. Hopman, G.F. Pieters, J.B. Jansen, A.G. Smals, G. Rosenbusch, et al.
Postprandial gallbladder motility during long term treatment with the long-acting somatostatin analogue SMS 201-995 in acromegaly.
Clin Endocrinol Metab, 69 (1989), pp. 557-562
[31.]
Z. Gimmon, R.E. Kelley, V. Simko, J.E. Fischer.
Total parenteral nutrition solution increases bile lithogenicity in the rat.
J Surg Res, 32 (1982), pp. 526-563
[32.]
G. Xu, G. Salen, A.K. Batta, S. Shefer, L.B. Nguyen, W. Niemann, et al.
Glycocholic acid and glycodeoxycholic acid but not glycoursocholic acid inhibit bile acid synthesis in the rabbit.
Gastrenterology, 102 (1992),
[33.]
A.F. Hofmann.
The colehepatic circulation of unconjugated bile acids: an update.
Bile acids and the hepatobiliary system, pp. 143-160
[34.]
P.E. Ross, A.N. Bott, C. Gallacher.
Cholesterol absortion in the gallbladder.
J Clin Pathol, 43 (1990), pp. 572-575
[35.]
M.C. Carey, M.J. Calahane.
Whither biliary sludge.
Gastroenterology, 95 (1988), pp. 508-523
[36.]
J.D. Ostrow.
Unconjugated bilirubin and cholesterol formation.
Hepatology, 12 (1990), pp. S219-S226
[37.]
R.L. Conter, J.J. Roslyn, H.A. Pitt.
Carbohydrate diet-induced calcium bilirubinate sludge and pigment gallstones in the prairie dog.
J Surg Res, 40 (1986), pp. 580-587
[38.]
M. Angelico, S. Candeloro de Sanctis, C. Gandin, D. Alvaro.
Spontaneous formation of pigmentary precipitates in bile saltdepleted rat bile and its prevention by micelle-forming bile salts.
Gastroenterolgy, 98 (1990), pp. 444-453
[39.]
R.T. Holzbach.
Recent progress in understanding cholesterol crystal nucleation as a precursor to human gallstone formation.
Hepatology, 6 (1986), pp. 1403-1406
[40.]
E.W. Toor, E.L. Cussler, D.F. Evans.
Cholesterol microcrystal growth in bile.
Clin Res, 25 (1977), pp. 320
[41.]
S. Gallinger, R.C. Harvey, C.N. Petrunka, R.G. Ilson, S.M. Strasberg.
Biliary proteins and the nucleation defect in cholesterol cholelithiasis.
Gastroenterology, 92 (1987), pp. 867-875
[42.]
J.M. Donovan, M.C. Carey.
Physical-chemical basis of gallstone formation.
Gastroenterol Clin North Am, 20 (1991), pp. 47-66
[43.]
D.J. Cabral, D.M. Small.
Physical chemistry of bile.
Handbook of Physiology-The Gastrointestinal System III. Section 6, pp. 621-662
[44.]
F. Cetta.
The role of bacteria in pigment gallstone disease.
Ann Surg, 213 (1991), pp. 315-326
[45.]
S. Myers, L. Bartula, B. Kalley-Taylor.
The role of prostaglandin I2 and billary lipids during evolving cholecystitis in the rabbit.
Gastroenterology, 104 (1993), pp. 248-255
Copyright © 2001. Elsevier España, S.L.. Todos los derechos reservados
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos